PM
$6.80
+1.02
(+17.65%)
As of Oct 5, 2026, 3:43 PM EDT
Price history
Picard Medical (PMI) is trading up at $6.80 (+17.65%), as of the latest quote. It operates in the Health Care sector.
IPO: August 29, 2025 · $4.00 offering · NYSE · View IPO details →
Picard Medical revenue & net income history (FY2024–FY2025)
RevenueNet income
| FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|
| Income statement | ||
| Revenue | $4.39M | $4.94M |
| Growth (year over year) | — | +12.5% |
| Gross profit | −$112.0K | −$204.0K |
| Gross margin | −2.6% | −4.1% |
| Operating income | −$13.7M | −$13.3M |
| Operating margin | −312.3% | −268.4% |
| Net income | −$21.1M | −$27.0M |
| Net margin | −479.5% | −546.6% |
| Balance sheet | ||
| Cash and equivalents | $96.0K | $7.45M |
| Total assets | $12.1M | $22.5M |
| Total liabilities | $35.8M | $18.8M |
| Shareholders' equity | −$44.0M | $3.79M |
| Cash flow | ||
| Operating cash flow | −$11.9M | −$15.7M |
RevenueNet income
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $881.0K | $836.0K | $620.0K | $2.13M | $1.19M | $1.00M | $1.15M | $2.95M |
| Growth (year over year) | — | — | −68.7% | +207.1% | +34.7% | +19.9% | +85.5% | +38.6% |
| Gross profit | −$673.0K | $136.0K | −$358.0K | −$127.0K | −$130.0K | $411.0K | $275.0K | $616.0K |
| Gross margin | −76.4% | 16.3% | −57.7% | −6.0% | −11.0% | 41.0% | 23.9% | 20.9% |
| Operating income | −$4.44M | −$3.57M | −$3.25M | −$3.52M | −$3.49M | −$3.00M | −$4.51M | −$4.63M |
| Operating margin | −504.4% | −427.3% | −523.5% | −165.2% | −293.8% | −299.7% | −392.3% | −156.7% |
| Net income | −$6.21M | −$8.84M | −$5.56M | −$6.72M | −$10.4M | −$4.29M | −$7.62M | −$5.66M |
| Net margin | −704.4% | −1057.2% | −896.9% | −315.5% | −878.3% | −428.2% | −662.3% | −191.6% |
| Balance sheet | ||||||||
| Cash and equivalents | — | $96.0K | — | $410.0K | $2.81M | $7.45M | $121.0K | $38.0K |
| Total assets | — | $12.1M | — | $11.7M | $13.5M | $22.5M | $11.2M | $9.17M |
| Total liabilities | — | $35.8M | — | $45.9M | $5.55M | $18.8M | $12.7M | $7.45M |
| Shareholders' equity | −$35.4M | −$44.0M | −$48.9M | −$54.5M | $7.97M | $3.79M | −$1.45M | $1.72M |
| Cash flow | ||||||||
| Operating cash flow | −$2.61M | −$3.15M | −$2.24M | −$2.54M | −$6.51M | −$4.38M | −$3.80M | −$1.35M |
| Capital expenditure | — | — | $0 | $0 | — | — | $26.0K | $0 |
| Free cash flow | — | — | −$2.24M | −$2.54M | — | — | −$3.83M | −$1.35M |
From Picard Medical's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Picard Medical
- Headquarters
- Tucson, Arizona From SEC filings, Oct 2026
Recent News (3)
-
Canada's services PMI shows sector shrinking for fourth straight month Canada's services PMI shows sector shrinking for fourth straight month Reuters
-
Germany flash manufacturing PMI rises to 4-month high of 43.2 Germany flash manufacturing PMI rises to 4-month high of 43.2
-
Germany flash services PMI falls to 9-month low of 49.4 Germany flash services PMI falls to 9-month low of 49.4
Other Health Care companies to compare with PMI
- PHR Phreesia Inc
- PLRX Pliant Therapeutics
- PLSE Pulse Biosciences Inc
- PLX Protalix Biotherapeutics Inc
- PMVP PMV Pharmaceuticals
- PNTG Pennant Group Inc
- PRAX Praxis Precision Medicines Inc
- PRCT Procept Biorobotics Corp